- PT
- |
- EN
Bozza’s research team activities involve clinical and translational research on severe emerging and re-emerging infectious diseases. The investigations have focused on the long-term outcomes of severe infections, including the neuro-cognitive consequences of sepsis, malaria, and HIV. In recent years, he also worked in the consolidation of new collaborative initiatives of clinical research in Brazil and Latin America to fill the gaps of knowledge regarding the management of critically ill patients in developing countries and the development of large collaborative studies in these settings.
EDUCATION
Medical Residence, Internal Medicine, Federal University of Rio de Janeiro
PhD, Pharmacology, Oswaldo Cruz Foundation
Postdoctoral Fellow, Molecular Biology, University of Utah
INVESTIGATION AREAS
Intensive Care
ADITIONAL INFORMATION
Bastos LS, Ranzani OT, Souza TML, Hamacher S, Bozza FA. COVID-19 hospital admissions: Brazil’s first and second waves compared. Lancet Respir Med. 2021 Aug;9(8):e82-e83.
doi: 10.1016/S2213-2600(21)00287-3
Kurtz P, Bastos LSL, Dantas LF, Zampieri FG, Soares M, Hamacher S, Salluh JIF, Bozza FA. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med. 2021 May;47(5):538-548.
doi: 10.1007/s00134-021-06388-0
Dantas LF, Peres IT, Bastos LSL, Marchesi JF, de Souza GFG, Gelli JGM, Baião FA, Maçaira P, Hamacher S, Bozza FA. App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning. PLoS One. 2021 Mar25;16(3):e0248920.
doi: 10.1371/journal.pone.0248920
Peres IT, Bastos LSL, Gelli JGM, Marchesi JF, Dantas LF, Antunes BBP, Maçaira PM, Baião FA, Hamacher S, Bozza FA. Sociodemographic factors associated with COVID-19 in-hospital mortality in Brazil. Public Health. 2021 Mar;192:15-20.
doi: 10.1016/j.puhe.2021.01.005
Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baião F, Hamacher S, Bozza FA. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021 Apr;9(4):407-418.
doi: 10.1016/S2213-2600(20)30560-9
19/10/2023
